AHA/ACC/Multisociety Cholesterol Guidelines: highlights
Therapeutic Advances in Cardiovascular Disease · 2019-01 · 13
DOI: 10.1177/1753944719881579 ↗Kurz gefasst
Leitlinie in der Zeitschrift Therapeutic Advances in Cardiovascular Disease, online erschienen am 07.10.2019. Verfasst von Ishwarlal Jialal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Veterans Affairs Medical Center, Mather, CA and Assistant Dean of Research, California North-State University, College of Medicine, 7300 Taron Road, …. Hauptthemen laut MEDLINE: Risk Reduction Behavior. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Veterans Affairs Medical Center, Mather, CA and Assistant Dean of Research, California North-State University, College of Medicine, 7300 Taron Road, Elk Grove, CA 95757, USA.
- Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA.
ORCID-Profile: Ishwarlal Jialal
Zitieren
APA
Jialal, I., & Devaraj, S. (2019). AHA/ACC/Multisociety Cholesterol Guidelines: highlights. Therapeutic Advances in Cardiovascular Disease, 13. https://doi.org/10.1177/1753944719881579
Vancouver
Jialal I, Devaraj S. AHA/ACC/Multisociety Cholesterol Guidelines: highlights. Therapeutic Advances in Cardiovascular Disease. 2019;13. doi:10.1177/1753944719881579
BibTeX
@article{Jialal2019,
author = {Jialal, Ishwarlal and Devaraj, Sridevi},
title = {AHA/ACC/Multisociety Cholesterol Guidelines: highlights},
journal = {Therapeutic Advances in Cardiovascular Disease},
year = {2019},
volume = {13},
doi = {10.1177/1753944719881579}
}
EUVIMED